Hospice News October 29, 2025
VITAS Healthcare has righted its ship when it comes to Medicare payment cap liabilities, paving the way for a brighter 2026.
The hospice provider, a subsidiary of Chemed Corp. (NYSE: CHE), accrued $6.1 million in Medicare Cap billing limitation in Q3 2025, compared to $2.2 million accrued in the third quarter of 2024. Of that amount, $4.6 million is associated with VITAS’ Florida operations. The remaining $1.5 million is associated with all other VITAS programs, with a concentration in California.
However, the company voiced confidence that its cap liability would fall in Fiscal Year 2026. Underlying this prediction was an effort by VITAS to increase admissions resulting from hospital referrals, as opposed to other settings.
“Management continues to believe there...
Today's Sponsors
Today's Sponsor